BSP 2024 will bring the parasitological community together to discuss the latest findings in parasite biology and progress in controlling disease. Their ambition is for the meeting to reach across divides, whether they be between parasites, all our scientific sessions that cut across taxonomy, or between countries, nearly half of our invited speakers come from outside the UK, or between generations, half of our speakers will be early-career researchers.
Scientific sessions will span the complete parasitological spectrum. From discovering the basic principles of parasite biology (‘Antigenic variation’, ‘Evolutionary origins of parasitism’), including the latest trends in parasite research (‘Cellular heterogeneity’, ‘Subcellular structure’, ‘Population variation’, ‘Organoid infection models’, ‘Parasite-immune interactions’, ‘Parasite-microbiome interactions’ and ‘Artificial Intelligence’), to applied parasitology for controlling disease (‘Drug development’, ‘Disease elimination’, ‘Epidemiology’, ‘Veterinary vaccines’, ‘Vector control’).
Sessions
Drug development 1 – Sponsored by DNDi
Date: Wednesday, 3 April 2024
Time: 11:10-12:50
| Keynote: Development of alternative treatments for filarial diseases Sabine Specht, Head of Filarial Disease, DNDi |
| Pharmacological targeting of bioactive lipid production improves experimental lymphatic filariasis pathology Shrilakshmi Hegde, Postdoctoral Research Associate, Liverpool School of Tropical Medicine |
| Stem cell screening to identify novel drug targets in the human parasite Schistosoma mansoni Sewwandi Perera, Student, Kingston University London |
| Development of azaquinazoline anti-Wolbachia drugs for veterinary zoonotic filariasis Jessica Dagley, Research Assistant, Liverpool School of Tropical Medicine |
| Developing the natural product Corallopyronin A to treat filariasis Kenneth Pfarr, Research Scientist, Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn |
